nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—L-DOPA—Melphalan—ovarian cancer	0.611	1	CrCrCtD
Masoprocol—CYP19A1—Paclitaxel—ovarian cancer	0.0794	1	CbGbCtD
Masoprocol—CYP19A1—follicular fluid—ovarian cancer	0.0335	0.227	CbGeAlD
Masoprocol—CYP19A1—corpus luteum—ovarian cancer	0.0193	0.131	CbGeAlD
Masoprocol—CYP19A1—ovarian follicle—ovarian cancer	0.0151	0.102	CbGeAlD
Masoprocol—IGF1R—embryo—ovarian cancer	0.00554	0.0374	CbGeAlD
Masoprocol—IGF1R—Irinotecan—Topotecan—ovarian cancer	0.00553	0.727	CbGdCrCtD
Masoprocol—LTB4R—uterine cervix—ovarian cancer	0.00543	0.0367	CbGeAlD
Masoprocol—IGF1R—epithelium—ovarian cancer	0.00452	0.0305	CbGeAlD
Masoprocol—LTB4R—bone marrow—ovarian cancer	0.00384	0.026	CbGeAlD
Masoprocol—IGF1R—gonad—ovarian cancer	0.00376	0.0254	CbGeAlD
Masoprocol—LTB4R—female gonad—ovarian cancer	0.0037	0.025	CbGeAlD
Masoprocol—LTB4R—vagina—ovarian cancer	0.00368	0.0249	CbGeAlD
Masoprocol—IGF1R—female reproductive system—ovarian cancer	0.00336	0.0227	CbGeAlD
Masoprocol—LTB4R—testis—ovarian cancer	0.00328	0.0222	CbGeAlD
Masoprocol—IGF1R—female gonad—ovarian cancer	0.00305	0.0206	CbGeAlD
Masoprocol—IGF1R—vagina—ovarian cancer	0.00303	0.0205	CbGeAlD
Masoprocol—CYP2J2—endometrium—ovarian cancer	0.00275	0.0186	CbGeAlD
Masoprocol—Isoprenaline—MAPK1—ovarian cancer	0.00273	1	CrCbGaD
Masoprocol—IGF1R—testis—ovarian cancer	0.00271	0.0183	CbGeAlD
Masoprocol—CYP2J2—uterus—ovarian cancer	0.00253	0.0171	CbGeAlD
Masoprocol—LTB4R—lymph node—ovarian cancer	0.00238	0.0161	CbGeAlD
Masoprocol—ALOX5—decidua—ovarian cancer	0.00228	0.0154	CbGeAlD
Masoprocol—CYP2J2—female reproductive system—ovarian cancer	0.00227	0.0154	CbGeAlD
Masoprocol—CYP2J2—vagina—ovarian cancer	0.00206	0.0139	CbGeAlD
Masoprocol—IGF1R—lymph node—ovarian cancer	0.00196	0.0133	CbGeAlD
Masoprocol—CYP2J2—testis—ovarian cancer	0.00184	0.0124	CbGeAlD
Masoprocol—ALOX5—female reproductive system—ovarian cancer	0.00179	0.0121	CbGeAlD
Masoprocol—ALOX5—bone marrow—ovarian cancer	0.00169	0.0114	CbGeAlD
Masoprocol—ALOX5—female gonad—ovarian cancer	0.00163	0.011	CbGeAlD
Masoprocol—CYP19A1—endometrium—ovarian cancer	0.0015	0.0101	CbGeAlD
Masoprocol—ALOX5—testis—ovarian cancer	0.00145	0.00978	CbGeAlD
Masoprocol—CYP19A1—gonad—ovarian cancer	0.00139	0.00938	CbGeAlD
Masoprocol—CYP19A1—uterus—ovarian cancer	0.00138	0.00932	CbGeAlD
Masoprocol—CYP19A1—female reproductive system—ovarian cancer	0.00124	0.00838	CbGeAlD
Masoprocol—CYP19A1—female gonad—ovarian cancer	0.00113	0.00762	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Epirubicin—ovarian cancer	0.00108	0.142	CbGdCrCtD
Masoprocol—ALOX5—lymph node—ovarian cancer	0.00105	0.00709	CbGeAlD
Masoprocol—CYP19A1—testis—ovarian cancer	0.001	0.00676	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Doxorubicin—ovarian cancer	0.001	0.131	CbGdCrCtD
Masoprocol—CYP19A1—lymph node—ovarian cancer	0.000725	0.0049	CbGeAlD
Masoprocol—IGF1R—Focal Adhesion—ERBB2—ovarian cancer	0.000256	0.00169	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—HRAS—ovarian cancer	0.000254	0.00168	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PIK3CB—ovarian cancer	0.000252	0.00167	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—PTEN—ovarian cancer	0.00025	0.00166	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IL6—ovarian cancer	0.00025	0.00166	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000247	0.00163	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—AKT1—ovarian cancer	0.000246	0.00163	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6—ovarian cancer	0.000243	0.00161	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—AKT1—ovarian cancer	0.000242	0.0016	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ovarian cancer	0.000242	0.0016	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NME2—ovarian cancer	0.00024	0.00159	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—ovarian cancer	0.000239	0.00158	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL6—ovarian cancer	0.000235	0.00155	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BCL9—ovarian cancer	0.000232	0.00154	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—HRAS—ovarian cancer	0.000229	0.00152	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000228	0.00151	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND1—ovarian cancer	0.000226	0.0015	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000226	0.00149	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CTNNB1—ovarian cancer	0.000224	0.00148	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6—ovarian cancer	0.000219	0.00145	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PTEN—ovarian cancer	0.000218	0.00144	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DOK1—ovarian cancer	0.000216	0.00143	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—MAPK3—ovarian cancer	0.000214	0.00142	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000211	0.0014	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	0.000207	0.00137	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—MAPK1—ovarian cancer	0.000204	0.00135	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000203	0.00135	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PPP1CC—ovarian cancer	0.000203	0.00134	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	0.000203	0.00134	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	0.000202	0.00134	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.0002	0.00132	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	0.000199	0.00132	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—VEGFA—ovarian cancer	0.000197	0.0013	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000191	0.00127	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000191	0.00127	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	0.000189	0.00125	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	0.000189	0.00125	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000186	0.00123	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DOK1—ovarian cancer	0.000184	0.00122	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.000183	0.00121	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.000178	0.00118	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—MAPK1—ovarian cancer	0.000177	0.00117	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—ovarian cancer	0.000177	0.00117	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—PIK3CA—ovarian cancer	0.000177	0.00117	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYTB—ovarian cancer	0.000173	0.00115	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PPP1CC—ovarian cancer	0.000173	0.00114	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000169	0.00112	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000166	0.0011	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—ovarian cancer	0.000165	0.00109	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.000164	0.00109	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—HRAS—ovarian cancer	0.000163	0.00108	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000156	0.00103	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYTB—ovarian cancer	0.000155	0.00102	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PIK3CA—ovarian cancer	0.000154	0.00102	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HDAC6—ovarian cancer	0.000154	0.00102	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000152	0.001	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000152	0.001	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—BRIP1—ovarian cancer	0.000152	0.001	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPP1CC—ovarian cancer	0.000152	0.001	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000151	0.001	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCL8—ovarian cancer	0.000146	0.000965	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000145	0.000961	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—AKT1—ovarian cancer	0.000144	0.000955	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—HRAS—ovarian cancer	0.000142	0.000943	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000141	0.000935	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—YAP1—ovarian cancer	0.000136	0.000902	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPP1CC—ovarian cancer	0.000135	0.000894	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BRIP1—ovarian cancer	0.000135	0.000894	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—XIAP—ovarian cancer	0.000133	0.000883	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HDAC6—ovarian cancer	0.000131	0.000866	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SMARCA4—ovarian cancer	0.00013	0.000861	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EREG—ovarian cancer	0.000127	0.00084	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—AKT1—ovarian cancer	0.000126	0.000833	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NME2—ovarian cancer	0.000124	0.000818	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000123	0.000813	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PGR—ovarian cancer	0.000119	0.000787	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—YAP1—ovarian cancer	0.000116	0.000767	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—XIAP—ovarian cancer	0.000113	0.000751	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000112	0.000741	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SMARCA4—ovarian cancer	0.000111	0.000732	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PARP1—ovarian cancer	0.000111	0.000732	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00011	0.000731	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EREG—ovarian cancer	0.000108	0.000714	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6ST—ovarian cancer	0.000106	0.0007	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000105	0.000694	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000102	0.000677	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—YAP1—ovarian cancer	0.000102	0.000673	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CG—ovarian cancer	0.000102	0.000673	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PGR—ovarian cancer	0.000101	0.000669	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000101	0.000666	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.84e-05	0.000652	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CD—ovarian cancer	9.83e-05	0.000651	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	9.41e-05	0.000623	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PARP1—ovarian cancer	9.4e-05	0.000622	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	9.16e-05	0.000606	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	9.07e-05	0.0006	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—YAP1—ovarian cancer	9.06e-05	0.0006	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PPP2R1A—ovarian cancer	8.97e-05	0.000594	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.96e-05	0.000594	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CD—ovarian cancer	8.93e-05	0.000591	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.84e-05	0.000585	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	8.84e-05	0.000585	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CB—ovarian cancer	8.57e-05	0.000568	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.54e-05	0.000566	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—FASN—ovarian cancer	8.28e-05	0.000549	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL8—ovarian cancer	8.24e-05	0.000545	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC5A5—ovarian cancer	8.15e-05	0.00054	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	7.98e-05	0.000529	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYTB—ovarian cancer	7.96e-05	0.000527	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.88e-05	0.000522	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—ovarian cancer	7.87e-05	0.000521	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC2A1—ovarian cancer	7.87e-05	0.000521	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CB—ovarian cancer	7.78e-05	0.000515	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.78e-05	0.000515	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.71e-05	0.00051	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PPP2R1A—ovarian cancer	7.62e-05	0.000505	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1B1—ovarian cancer	7.55e-05	0.0005	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL8—ovarian cancer	7.48e-05	0.000495	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—FASN—ovarian cancer	7.38e-05	0.000489	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	7.34e-05	0.000486	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC5A5—ovarian cancer	7.26e-05	0.000481	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	7.18e-05	0.000476	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	7.18e-05	0.000476	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—ovarian cancer	7.15e-05	0.000473	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TERT—ovarian cancer	7.12e-05	0.000472	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC2A1—ovarian cancer	7.01e-05	0.000464	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPP1CC—ovarian cancer	6.96e-05	0.000461	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BRIP1—ovarian cancer	6.96e-05	0.000461	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.87e-05	0.000455	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	6.79e-05	0.000449	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1B1—ovarian cancer	6.73e-05	0.000445	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPP2R1A—ovarian cancer	6.69e-05	0.000443	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.66e-05	0.000441	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CAV1—ovarian cancer	6.59e-05	0.000436	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ESR1—ovarian cancer	6.35e-05	0.00042	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6ST—ovarian cancer	6.25e-05	0.000414	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCB1—ovarian cancer	6.21e-05	0.000411	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMS—ovarian cancer	6.1e-05	0.000404	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TERT—ovarian cancer	6.06e-05	0.000401	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	6.03e-05	0.000399	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CG—ovarian cancer	6e-05	0.000397	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APC—ovarian cancer	6e-05	0.000397	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—NRAS—ovarian cancer	6e-05	0.000397	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPP2R1A—ovarian cancer	5.96e-05	0.000395	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.94e-05	0.000393	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK3—ovarian cancer	5.75e-05	0.000381	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CAV1—ovarian cancer	5.6e-05	0.000371	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCB1—ovarian cancer	5.54e-05	0.000367	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK1—ovarian cancer	5.47e-05	0.000362	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—ovarian cancer	5.47e-05	0.000362	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMS—ovarian cancer	5.44e-05	0.00036	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ESR1—ovarian cancer	5.4e-05	0.000357	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6ST—ovarian cancer	5.31e-05	0.000352	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CD—ovarian cancer	5.28e-05	0.000349	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CA—ovarian cancer	5.23e-05	0.000346	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KRAS—ovarian cancer	5.16e-05	0.000342	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APC—ovarian cancer	5.1e-05	0.000338	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CG—ovarian cancer	5.1e-05	0.000338	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	5.09e-05	0.000337	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.07e-05	0.000336	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAV1—ovarian cancer	4.92e-05	0.000326	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CA—ovarian cancer	4.75e-05	0.000314	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.7e-05	0.000311	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—YAP1—ovarian cancer	4.67e-05	0.000309	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB2—ovarian cancer	4.66e-05	0.000309	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.62e-05	0.000306	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MTOR—ovarian cancer	4.6e-05	0.000304	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CB—ovarian cancer	4.6e-05	0.000304	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CD—ovarian cancer	4.49e-05	0.000297	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CG—ovarian cancer	4.48e-05	0.000297	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL8—ovarian cancer	4.42e-05	0.000293	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRAS—ovarian cancer	4.39e-05	0.000291	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAV1—ovarian cancer	4.38e-05	0.00029	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1B—ovarian cancer	4.32e-05	0.000286	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—ovarian cancer	4.27e-05	0.000283	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—ovarian cancer	4.23e-05	0.00028	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—ovarian cancer	4.22e-05	0.00028	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—ovarian cancer	4.2e-05	0.000278	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.19e-05	0.000277	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—ovarian cancer	4.12e-05	0.000273	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CTNNB1—ovarian cancer	4.08e-05	0.00027	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.06e-05	0.000269	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—ovarian cancer	4e-05	0.000265	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CG—ovarian cancer	3.99e-05	0.000264	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTEN—ovarian cancer	3.97e-05	0.000263	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB2—ovarian cancer	3.96e-05	0.000262	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CD—ovarian cancer	3.94e-05	0.000261	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CB—ovarian cancer	3.91e-05	0.000259	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MTOR—ovarian cancer	3.91e-05	0.000259	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—ovarian cancer	3.88e-05	0.000257	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—FASN—ovarian cancer	3.8e-05	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL8—ovarian cancer	3.76e-05	0.000249	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC5A5—ovarian cancer	3.74e-05	0.000248	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1B—ovarian cancer	3.67e-05	0.000243	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A1—ovarian cancer	3.61e-05	0.000239	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—ovarian cancer	3.6e-05	0.000238	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—ovarian cancer	3.59e-05	0.000238	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—ovarian cancer	3.59e-05	0.000238	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—ovarian cancer	3.55e-05	0.000235	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NRAS—ovarian cancer	3.54e-05	0.000235	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.54e-05	0.000234	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CD—ovarian cancer	3.51e-05	0.000232	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—ovarian cancer	3.5e-05	0.000232	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CTNNB1—ovarian cancer	3.47e-05	0.00023	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1B1—ovarian cancer	3.46e-05	0.000229	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CB—ovarian cancer	3.43e-05	0.000227	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—ovarian cancer	3.4e-05	0.000225	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK3—ovarian cancer	3.4e-05	0.000225	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTEN—ovarian cancer	3.38e-05	0.000224	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—ovarian cancer	3.3e-05	0.000219	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK1—ovarian cancer	3.23e-05	0.000214	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—ovarian cancer	3.23e-05	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	3.07e-05	0.000203	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CB—ovarian cancer	3.06e-05	0.000203	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.06e-05	0.000202	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—ovarian cancer	3.05e-05	0.000202	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KRAS—ovarian cancer	3.05e-05	0.000202	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—ovarian cancer	3.02e-05	0.0002	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NRAS—ovarian cancer	3.01e-05	0.0002	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTEN—ovarian cancer	2.97e-05	0.000196	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK3—ovarian cancer	2.89e-05	0.000191	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCB1—ovarian cancer	2.85e-05	0.000189	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—ovarian cancer	2.81e-05	0.000186	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CA—ovarian cancer	2.8e-05	0.000186	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMS—ovarian cancer	2.8e-05	0.000186	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK1—ovarian cancer	2.75e-05	0.000182	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—ovarian cancer	2.75e-05	0.000182	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—ovarian cancer	2.71e-05	0.00018	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTEN—ovarian cancer	2.64e-05	0.000175	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KRAS—ovarian cancer	2.59e-05	0.000172	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRAS—ovarian cancer	2.59e-05	0.000172	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—ovarian cancer	2.48e-05	0.000164	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CA—ovarian cancer	2.38e-05	0.000158	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—ovarian cancer	2.31e-05	0.000153	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—ovarian cancer	2.29e-05	0.000152	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAV1—ovarian cancer	2.26e-05	0.00015	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRAS—ovarian cancer	2.21e-05	0.000146	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.16e-05	0.000143	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—ovarian cancer	2.11e-05	0.00014	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CA—ovarian cancer	2.09e-05	0.000139	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CG—ovarian cancer	2.06e-05	0.000136	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—ovarian cancer	1.95e-05	0.000129	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CA—ovarian cancer	1.86e-05	0.000123	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CD—ovarian cancer	1.81e-05	0.00012	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—ovarian cancer	1.71e-05	0.000113	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CB—ovarian cancer	1.58e-05	0.000104	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—ovarian cancer	1.52e-05	0.000101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTEN—ovarian cancer	1.36e-05	9.02e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CA—ovarian cancer	9.61e-06	6.36e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—ovarian cancer	7.85e-06	5.2e-05	CbGpPWpGaD
